“ipos” Archives

in
Entry Author Date Location
West Coast Biotech Roundup: Alder IPO, Exelixis, Corcept, and More 05/09/14 San Diego
San Diego’s Ambrx Files for IPO to Advance Antibody-Drug Conjugates 05/05/14 San Diego
San Diego Life Sciences Roundup: Otonomy, Verdezyne, and IPOs 05/02/14 San Diego
At Two-Year Mark, JOBS Act Is Regulation Even A Biotech Can Love 05/01/14 San Francisco
How A Kidney Drug Almost Torpedoed Concert Pharma’s IPO 04/25/14 Boston
San Diego Life Sciences Roundup: Illumina, Vital Therapies, and More 04/24/14 San Diego
New Ignition Partners Happy Betting on Business Computing Renaissance 04/23/14 Seattle
Zafgen Lines Up $86M IPO to Bankroll Obesity Drug Push 04/20/14 Boston
Investing in Dreams: Northwest Programs Educate New Angels 04/14/14 Seattle
San Diego Life Sciences Roundup: Celladon, Halozyme, Zogenix, & More 04/11/14 San Diego
Venture-Backed IPOs & Late-Stage Investments Surged in Q1 04/10/14 National
San Diego Life Sciences Roundup: Halozyme, NuVasive, Lumena, and More 04/07/14 San Diego
San Diego’s Lumena Files for IPO to Fund Liver Drug Trials 04/04/14 San Diego
Syndax Plots $69M IPO For Cancer Drug’s Stretch Run 03/27/14 Boston
Ariosa Takes Pre-Natal Genetic Test to Wall Street, Eyes $69M IPO 03/25/14 San Francisco
Boston Tech Roundup: Flybridge, Globoforce, Boston Seed, & More 03/24/14 Boston
A ‘Sleeper’ No More: Actifio Raises $100M, Deferring IPO Plans 03/24/14 Boston
Alder BioPharmaceuticals Hits IPO Trail Looking for $115M 03/19/14 Seattle
San Diego Life Sciences Roundup: Zogenix, Ignyta, AnaptysBio, & More 03/17/14 San Diego
East Coast Biotech Roundup: Sigal, Radius, SHIN-NY, & More 02/28/14 Boston
Revamped Radius Health Looks to Cash In With $86M IPO 02/27/14 Boston
2014 Trends in Early-Stage Life Sciences Investment 02/20/14 Boston
East Coast Biotech Roundup: Voyager, Concert, Retrophin, & More 02/14/14 Boston
Concert Pharma Heads to Nasdaq, Prices IPO at $14 Per Share 02/13/14 Boston
Flexion Prices IPO at $13, Heads to Nasdaq Tomorrow 02/11/14 Boston
Boston Tech Roundup: DataXu, Imprivata, Flashnotes 02/07/14 Boston
East Coast Biotech Roundup: Genocea, Eleven, NIH/Pharma, & More 02/07/14 Boston
San Diego Life Sciences Roundup: Auspex, Biocept, Halozyme & More 02/07/14 San Diego
Vaccine Developer Genocea Prices IPO at $12 Per Share 02/05/14 Boston
San Diego Life Sciences Roundup: Accelrys, Celladon’s IPO, and More 01/31/14 San Diego
Page 3 of 17 « previous page · next page »